In a similar manner, ULBP2-BB4, a bispecific antibody that links tumor CD138 with the NK cell receptor NKG2D, was able to activate NK cells [330], leading to an increase in the production of IFN-γ and the destruction of cancer cells [330]. The gene discussed is KLRK1; the disease is neoplasm.